Dr. Anil Aribandi
Rating
4.9/5
Total Surgeries
1000+
Category
Best In Country
Specialization : Hematology
Position held
Senior Consultant Haemato-Oncologist and Bone Marrow Transplant Specialist at the Citizens Specialty Hospital, Hyderabad
1000+
Expert Complex
Procedures Performed
Specialization
Haemato-oncology
Stem Cell Transplantation
Clinical Hematology
Hemostasis and thrombosis
Key Treatments
- Leukemia
- Lymphoma
- Myeloma
- Amyloidosis
- Autologous
- Allogeneic
- Thalassemia
- Sickle cell anemia
- Iron deficiency
- Myelodysplastic syndromes
Affiliations
European Society of Blood and Marrow Transplantation (EBMT)
British Society of Hematology
European Hematology Association
International Society on Thrombosis & Hemostasis
Royal College of Pathologist
Royal College of Physicians & Surgeons (Glasgow)
Indian Society of Hematology & Blood transfusion
Indian Medical Association
Professional Summary
Dr. Anil Aribandi is one of the leading physicians in Haemato Oncology and is associated with American Oncology Institute, Hyderabad as Sr. Consultant Haematology, Haemato-Oncology and Bone Marrow Transplantation (BMT). He earned his medical degree from Kakatiya Medical College, Hyderabad, Telangana, India. He then completed his Masters in General Medicine from Osmania Medical College, Hyderabad, Telangana, India. He pursued his higher medical training program in clinical Hematology in the United Kingdom leading to FRCPath (Hematology) degree.
Dr. Anil has been trained in Hematology in the UK and has been a consultant in NHS, UK. As an experienced Haemato-oncologist, he has expertise in blood and blood related disorders including leukaemia, myelodysplastic syndromes, lymphomas, multiple myeloma, amyloidosis, bone marrow/stem cell transplant, bleeding and clotting disorders, thalassemias and sickle cell anaemia, aplastic anaemia, complicated anemias amongst Others.
Dr. Anil has been awarded Certificate of completion of specialist training (CCT) and then enlisted in the Specialist Register as a fully qualified Haemato-oncologist with licence to practise as an independent Consultant by General Medical Council (GMC), United Kingdom.
Publications
Complex Bleeding Management-Multidisciplinary Approach. Anil Aribandi, CS Ranjith, K Ashok, Rajesh Mallik Gottipati. Res Pract Thromb Haemost, 2022
Hematological complications of Covid Immunization-Case series. Anil Aribandi, CS Ranjith Kumar, K Ashok Kumar, HemaSphere, 2022.
Generic Elthrombopag with standard Immunosuppressive therapy in Severe Aplastic Anemia. CS Ranjith Kumar, Anil Aribandi, K Ashok kumar. HemaSphere, 2022.
A case of double positive myeloproliferative neoplasm: A diagnostic and therapeutic challenge Anil Aribandi, Anurag Gupta, Suresh K Subramanian Manu Goyal. Indian J Pathol Microbiol Oct-Dec 2021;64(4):820-823.
Refractory Thrombotic Thrombocytopenic Purpura - A Case Report A. Aribandi, C. Ranjith, S. Sushma, T. Surapaneni Res Pract Thromb Hemost. 2021.
Successful Pregnancy in a Patient with Factor XIII Deficiency and Recurrent Miscarriages [abstract]. Surapaneni T, Vadlamani H, Sukayogula M, Ranjith C, Aribandi A. Res Pract Thromb Haemost. 2021; 5 (Suppl 2)
Varied Presentations of TTP. Aribandi A, Ranjith CS. [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1)
Tuberculosis reactivation following ruxolitinib therapy for myelofibrosis Anil Aribandi, Ranjit Kumar.CS, Rajesh M. Gottipati HemaSphere, 2021;5:(S2)
Profile of Hemophagocytic Lymphohistiocytosis (HLH) Prospective observational study Sirisharani Siddaiahgari, Archana Rauthan, Ranjith CS, JoydeepChakrabartty, Anil Aribandi HemaSphere, 2021;5:(S2)
Neutrophilic leukoaggregates--A rare hematological phenomenon. Sampath Kumar KJ, Lal S, Kalpati K, Lingutla AK, Aribandi A, Sharma A Indian J Pathol Microbiol. 2021 Jan-Mar;64(1):223-224